News shared by:

336 Articles
18 Nov 2018
AstraZeneca Sells Infant Drug Rights for $1.5B

Swedish Orphan Biovitrum AB (Sobi), has entered into a deal to acquire the rights to AstraZeneca’sSynagis (palivizumab) in the U.S. for $1.5 billion upfront, which includes $1 billion in...

18 Nov 2018
bioLIVE to merge with BioProduction Congress for 2019 event

  BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry. bioLIVE – the...

16 Nov 2018
CASI Pharmaceuticals to build new manufacturing site in China

CASI Pharmaceuticals, a biopharmaceutical company, announces that it has entered into framework agreements to build a state-of-the-art manufacturing site strategically located in the Wuxi Huishan...

16 Nov 2018
AbbVie, Mission Therapeutics join forces on Alzheimer’s, Parkinson’s

AbbVie and Mission Therapeutics inked an R&D pact focused on deubiquitylating enzymes (DUBs) in Alzheimer’s and Parkinson’s disease. By targeting these enzymes, the pair...

14 Nov 2018
USP article on pharmaceutical continuous manufacturing

In the latest edition of the Pharmacopoeial Forum 44(6), the US pharmacopoeia USP has published a so-called Stimuli Article on pharmaceutical continuous manufacturing. A continuous process means...

14 Nov 2018
How can predictive analytics help pharmaceutical manufacturing?

Predictive analytics can help pharmaceutical companies with better strategies, communication, and ways to meet the needs of end users… Predictive analytics uses existing data sets,...

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×